<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00731783</url>
  </required_header>
  <id_info>
    <org_study_id>3177 38145</org_study_id>
    <nct_id>NCT00731783</nct_id>
  </id_info>
  <brief_title>Staphylococcus Aureus Decolonization Study</brief_title>
  <acronym>SuDS</acronym>
  <official_title>Household vs. Individual Approach to Decolonization of Community-acquired Methicillin-resistant Staphylococcus Aureus.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether measures to eliminate the Staph germ from
      the skin of the index patient (with a special ointment and soap) are more effective when
      performed by everyone in the household rather than the patient alone, and whether these
      methods are effective in preventing future Staph infections. The investigators hypothesize
      that there will be a greater number of households who are successful in eradicating the staph
      germ from the index patient when all members of the household participate than households
      where only the index patient is treated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methicillin-resistant Staphylococcus aureus (MRSA) was once uniformly associated with
      hospital-acquired infections; however, MRSA strains have emerged that thrive outside the
      hospital environment, causing significant morbidity and mortality among immunocompetent
      individuals, leading to their designation as community-acquired methicillin resistant
      Staphylococcus aureus (CA-MRSA).

      CA-MRSA has become a major source of morbidity and mortality in our pediatric population. An
      important prerequisite for S. aureus infection may be nasal carriage of the organism. A
      variety of decolonization strategies have been used for infection prophylaxis, primarily in
      patients undergoing hemodialysis or surgery, with varying results. However, there are no
      published randomized eradication trials evaluating the decolonization and prevention of
      CA-MRSA infections in immunocompetent children in the outpatient setting. While the
      transmission of CA-MRSA within households has been reported, its contribution to recurrent
      CA-MRSA infection among household members is undetermined. The investigators hypothesize that
      spread of CA-MRSA among household members leads to recolonization or failure of
      decolonization in children undergoing eradication efforts.

      Specific Aim: In pediatric patients presenting with a MRSA skin or soft tissue infection,
      compare the effectiveness of decolonization measures performed by an entire household in
      comparison to measures directed at the index patient alone. The investigators will conduct a
      randomized, controlled trial to test the hypothesis that decolonization measures performed by
      the entire household, specifically application of intranasal mupirocin ointment and bathing
      with chlorhexidine liquid soap, in addition to education and basic hygiene interventions,
      will be twice as effective in eradicating CA-MRSA carriage in the index patient than if the
      measures are performed only by the index patient.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Index Patients Eradicated of S. Aureus Carriage - 1 Month After Performing Decolonization Measures</measure>
    <time_frame>1 month after enrollment.</time_frame>
    <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Index Patients Eradicated of S. Aureus Carriage - 3 Month After Performing Decolonization Measures</measure>
    <time_frame>3 month after enrollment.</time_frame>
    <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Index Patients Eradicated of S. Aureus Carriage - 6 Month After Performing Decolonization Measures</measure>
    <time_frame>6 month after enrollment.</time_frame>
    <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Index Patients Eradicated of S. Aureus Carriage - 12 Month After Performing Decolonization Measures</measure>
    <time_frame>12 month after enrollment.</time_frame>
    <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 1 Month After Enrollment.</measure>
    <time_frame>1 month after enrollment</time_frame>
    <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 3 Month After Enrollment.</measure>
    <time_frame>3 month after enrollment</time_frame>
    <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 6 Month After Enrollment.</measure>
    <time_frame>6 month after enrollment</time_frame>
    <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 12 Month After Enrollment.</measure>
    <time_frame>12 month after enrollment</time_frame>
    <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">183</enrollment>
  <condition>Staphylococcal Skin Infections</condition>
  <condition>Abscesses</condition>
  <condition>Furunculosis</condition>
  <condition>Staphylococcus Aureus</condition>
  <condition>MRSA Infection</condition>
  <arm_group>
    <arm_group_label>Index patient only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Household</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% Mupirocin Ointment</intervention_name>
    <description>Apply ointment to the anterior nares twice daily for 5 days.</description>
    <arm_group_label>Index patient only</arm_group_label>
    <arm_group_label>Household</arm_group_label>
    <other_name>Bactroban</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4% Chlorhexidine liquid soap</intervention_name>
    <description>Bathe with liquid soap daily for 5 days.</description>
    <arm_group_label>Index patient only</arm_group_label>
    <arm_group_label>Household</arm_group_label>
    <other_name>Hibiclens</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hygiene protocol</intervention_name>
    <description>Follow key hygiene tips indefinitely. Tips are:
Throw out all lotions or creams that you dip your hands into and replace with pumps or pour bottles.
Use liquid(pour or pump) soaps instead of bar soaps.
Wash hands frequently or use hand sanitizer(with more than %60 alcohol) such as Germ-X or Purell.
Do not share personal care items such as razors and brushes.
Wash all sheets and towels in hot water. Wash sheets every week.
Use towels and wash cloths only once before washing and do not share.</description>
    <arm_group_label>Index patient only</arm_group_label>
    <arm_group_label>Household</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Screening:

          -  Children aged 6 months to 21 years presenting with an active skin or soft tissue
             infection.

        Enrollment:

          -  Positive MRSA culture from the abscess and from either the axilla, anterior nares or
             groin area (signifying both infection and colonization with MRSA).

        Exclusion Criteria:

          -  Infants less than 6 months of age

          -  Dialysis or residence in a long term care facility over the past year

          -  Use of chlorhexidine or mupirocin in the past one month

          -  Pregnancy

          -  Immunodeficiency

          -  History of an adverse reaction to chlorhexidine or mupirocin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie A Fritz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Louis Children's Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2008</study_first_submitted>
  <study_first_submitted_qc>August 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2008</study_first_posted>
  <results_first_submitted>March 2, 2011</results_first_submitted>
  <results_first_submitted_qc>March 2, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 23, 2011</results_first_posted>
  <last_update_submitted>April 23, 2012</last_update_submitted>
  <last_update_submitted_qc>April 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington University School of Medicine</investigator_affiliation>
    <investigator_full_name>Stephanie A. Fritz</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Abscesses</keyword>
  <keyword>Furunculosis</keyword>
  <keyword>Staphylococcus aureus colonization</keyword>
  <keyword>Staphylococcal Skin Infections</keyword>
  <keyword>MRSA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Abscess</mesh_term>
    <mesh_term>Skin Diseases, Infectious</mesh_term>
    <mesh_term>Staphylococcal Skin Infections</mesh_term>
    <mesh_term>Furunculosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Mupirocin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Index Patient Only</title>
          <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen, which includes application of 2% Mupirocin Ointment to the anterior nares twice daily for 5 days and washing with 4% Chlorhexidine liquid soap daily for 5 days.</description>
        </group>
        <group group_id="P2">
          <title>Household</title>
          <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol, which includes application of 2% Mupirocin Ointment to the anterior nares twice daily for 5 days and washing with 4% Chlorhexidine liquid soap daily for 5 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>One Month Follow-Up Visit</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="92"/>
                <participants group_id="P2" count="91"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="78"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Three Month Follow-Up Visit</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="79"/>
                <participants group_id="P2" count="73"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="72"/>
                <participants group_id="P2" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Six Month Follow-Up Visit</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="77"/>
                <participants group_id="P2" count="67"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="64"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>12 Month Follow-Up Visit</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Index Patient Only</title>
          <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
        </group>
        <group group_id="B2">
          <title>Household</title>
          <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="92"/>
            <count group_id="B2" value="91"/>
            <count group_id="B3" value="183"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.3" spread="5.7"/>
                    <measurement group_id="B2" value="5.7" spread="6.0"/>
                    <measurement group_id="B3" value="6.0" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Index Patients Eradicated of S. Aureus Carriage - 1 Month After Performing Decolonization Measures</title>
        <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
        <time_frame>1 month after enrollment.</time_frame>
        <population>Modified intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Index Patient Only</title>
            <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
          </group>
          <group group_id="O2">
            <title>Household</title>
            <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Index Patients Eradicated of S. Aureus Carriage - 1 Month After Performing Decolonization Measures</title>
          <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
          <population>Modified intention to treat analysis</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="78"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>1.00</p_value>
            <method>Fisher Exact</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.54</ci_lower_limit>
            <ci_upper_limit>1.97</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Index Patients Eradicated of S. Aureus Carriage - 3 Month After Performing Decolonization Measures</title>
        <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
        <time_frame>3 month after enrollment.</time_frame>
        <population>Modified intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Index Patient Only</title>
            <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
          </group>
          <group group_id="O2">
            <title>Household</title>
            <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Index Patients Eradicated of S. Aureus Carriage - 3 Month After Performing Decolonization Measures</title>
          <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
          <population>Modified intention to treat analysis</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="72"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.05</p_value>
            <method>Fisher Exact</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.17</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.03</ci_lower_limit>
            <ci_upper_limit>4.55</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Index Patients Eradicated of S. Aureus Carriage - 6 Month After Performing Decolonization Measures</title>
        <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
        <time_frame>6 month after enrollment.</time_frame>
        <population>Modified intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Index Patient Only</title>
            <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
          </group>
          <group group_id="O2">
            <title>Household</title>
            <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Index Patients Eradicated of S. Aureus Carriage - 6 Month After Performing Decolonization Measures</title>
          <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
          <population>Modified intention to treat analysis</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.49</p_value>
            <method>Fisher Exact</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.77</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.39</ci_lower_limit>
            <ci_upper_limit>1.52</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Index Patients Eradicated of S. Aureus Carriage - 12 Month After Performing Decolonization Measures</title>
        <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
        <time_frame>12 month after enrollment.</time_frame>
        <population>Modified intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Index Patient Only</title>
            <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
          </group>
          <group group_id="O2">
            <title>Household</title>
            <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Index Patients Eradicated of S. Aureus Carriage - 12 Month After Performing Decolonization Measures</title>
          <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient.</description>
          <population>Modified intention to treat analysis</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
                <count group_id="O2" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.28</p_value>
            <method>Fisher Exact</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.59</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.77</ci_lower_limit>
            <ci_upper_limit>3.28</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 1 Month After Enrollment.</title>
        <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
        <time_frame>1 month after enrollment</time_frame>
        <population>Modified intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Index Patient Only</title>
            <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
          </group>
          <group group_id="O2">
            <title>Household</title>
            <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
          </group>
        </group_list>
        <measure>
          <title>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 1 Month After Enrollment.</title>
          <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
          <population>Modified intention to treat analysis</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="81"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.12</p_value>
            <method>Fisher Exact</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.52</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.23</ci_lower_limit>
            <ci_upper_limit>1.16</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 3 Month After Enrollment.</title>
        <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
        <time_frame>3 month after enrollment</time_frame>
        <population>Modified intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Index Patient Only</title>
            <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
          </group>
          <group group_id="O2">
            <title>Household</title>
            <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
          </group>
        </group_list>
        <measure>
          <title>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 3 Month After Enrollment.</title>
          <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
          <population>Modified intention to treat analysis</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Fisher Exact</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.42</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.21</ci_lower_limit>
            <ci_upper_limit>0.85</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 6 Month After Enrollment.</title>
        <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
        <time_frame>6 month after enrollment</time_frame>
        <population>Modified intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Index Patient Only</title>
            <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
          </group>
          <group group_id="O2">
            <title>Household</title>
            <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
          </group>
        </group_list>
        <measure>
          <title>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 6 Month After Enrollment.</title>
          <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
          <population>Modified intention to treat analysis</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <method>Fisher Exact</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.39</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.20</ci_lower_limit>
            <ci_upper_limit>0.77</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 12 Month After Enrollment.</title>
        <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
        <time_frame>12 month after enrollment</time_frame>
        <population>Modified intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Index Patient Only</title>
            <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
          </group>
          <group group_id="O2">
            <title>Household</title>
            <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
          </group>
        </group_list>
        <measure>
          <title>Recurrence of CA-MRSA Skin or Soft Tissue Infection - 12 Month After Enrollment.</title>
          <description>Recurrence of CA-MRSA Skin or Soft Tissue Infection</description>
          <population>Modified intention to treat analysis</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="78"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Fisher Exact</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.43</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.22</ci_lower_limit>
            <ci_upper_limit>0.86</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected by phone approximately 7-10 days following study enrollment. The intervention only lasted 5 days and thus all adverse events would have happened by this time.</time_frame>
      <desc>There are more participants with data on adverse events than data on the primary outcome measure because some participants completed the follow-up phone call at 7-10 days (where adverse events were assessed) but failed to complete the 1 month follow-up visit (where primary outcome measure was assessed).</desc>
      <group_list>
        <group group_id="E1">
          <title>Index Patient Only</title>
          <description>Only the child recently treated for a skin or soft tissue infection will undergo the decolonization regimen.</description>
        </group>
        <group group_id="E2">
          <title>Household</title>
          <description>All members of the household (over the age of 6 months) will be asked to follow the study protocol.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dry Skin</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="77"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Stephanie A. Fritz, M.D., M.S.C.I.</name_or_title>
      <organization>Washington University</organization>
      <phone>314-454-6050</phone>
      <email>fritz_s@kids.wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

